Showing 1 - 7 results of 7 for search 'Semira Abdi', query time: 0.03s Refine Results
  1. 1
    Choice of Antimicrobials in Surgical Prophylaxis - Overuse and Surgical Site Infection Outcomes from a Tertiary-Level Care Hospital

    Choice of Antimicrobials in Surgical Prophylaxis - Overuse and Surgical Site Infection Outcomes from a Tertiary-Level Care Hospital by Prasanna Vippadapu, Syed Wasif Gillani, Dixon Thomas, Fiaz Ahmed, Shabaz Mohiuddin Gulam, Shabaz Mohiuddin Gulam, Rana Kamran Mahmood, Rana Kamran Mahmood, Vineetha Menon, Semira Abdi, Semira Abdi, Hassaan Anwer Rathore

    Published 2022-04-01
    Get full text
    Article
  2. 2
    Assessment of Predicted Rate and Associated Factors of Dabigatran-induced Bleeding Events in Malaysian Patients with Non-Valvular Atrial Fibrillation

    Assessment of Predicted Rate and Associated Factors of Dabigatran-induced Bleeding Events in Malaysian Patients with Non-Valvular Atrial Fibrillation by Semira Abdi Beshir, Lok Bin Yap, Szyuin Sim, Kok Han Chee, Yoke Lin Lo

    Published 2018-01-01
    Get full text
    Article
  3. 3
    Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants

    Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants by Beshir, Semira Abdi, Aziz, Zoriah, Yap, Lok Bin, Chee, Kok Han, Lo, Yoke Lin

    Published 2017
    Article
  4. 4
    A narrative review of approved and emerging anti-obesity medications

    A narrative review of approved and emerging anti-obesity medications by Semira Abdi Beshir, Asim Ahmed Elnour, Aadith Soorya, Affana Parveen Mohamed, Sheron Sir Loon Goh, Nadia Hussain, Amal H.I. Al Haddad, Faizah Hussain, Israa Yousif Khidir, Zainab Abdelnassir

    Published 2023-10-01
    Get full text
    Article
  5. 5
    Corrigendum to “A narrative review of approved and emerging anti-obesity medications” [Saudi Pharm. J. 31(10) (2023) 101757]

    Corrigendum to “A narrative review of approved and emerging anti-obesity medications” [Saudi Pharm. J. 31(10) (2023) 101757] by Semira Abdi Beshir, Asim Ahmed Elnour, Aadith Soorya, Affana Parveen Mohamed, Sheron Sir Loon Goh, Nadia Hussain, Amal H.I. Al Haddad, Faizah Hussain, Israa Yousif EL Khidir, Zainab Abdelnassir

    Published 2024-05-01
    Get full text
    Article
  6. 6
    The early mortality rate of people infected with coronavirus (COVID-2019) in Wuhan, China: Review of three retrospective studies

    The early mortality rate of people infected with coronavirus (COVID-2019) in Wuhan, China: Review of three retrospective studies by Asim Ahmed Elnour, Judit Don, Isra Yousif, Kishore Gnana, Semira Abdi, Noora Al Hajri, Abdulla Al Amoodi, Ahmed Ibrahim Fathelrahman, Salma Mohammed Magboul1, Sasha Mohamed, Sahar Asim Ahmed, Adel Sadeq

    Published 2020-01-01
    Get full text
    Article
  7. 7
    The flavonoid luteolin reduces mutant huntingtin aggregation and cytotoxicity in huntingtin-mutated neuroblastoma cells

    The flavonoid luteolin reduces mutant huntingtin aggregation and cytotoxicity in huntingtin-mutated neuroblastoma cells by Azza Ramadan, Abuelnor Mohammed, Asim Ahmed Elnour, Adel Sadeq, Nadia Al Mazrouei, Maisoun Alkaabi, Khalid Awad Al-Kubaisi, Semira Abdi Beshir, Vineetha Menon, Abdulla AlAmoodi, Kishore Ganana Sam, Ali Awadallah Ali Mohamed Saeed, Sami Fatehi Abdalla, Samah Mohammed Hussein

    Published 2023-12-01
    Get full text
    Article

Search Tools: